H.Res. 709 · 113th Congress
Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a ''Valley of Death'' in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.
- Stage
- In committee
- Sponsor
- Juan Vargas
- Introduced
- 2014-07-31
- Latest action
- 2014-08-01 · Referred to the Subcommittee on Health.